Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

A reescalating battle between pharmaceutical companies and pharmacy benefit managers is brewing in Washington, D.C., as ...

CVS Health's MinuteClinic and Georgia-based Emory Healthcare are expanding their partnership to provide in-network primary ...

A CVS spokesperson said the Emory collaboration is the first time MinuteClinic has expanded into primary care services in ...

Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

Retail pharmacy chain CVS Health (CVS) is scheduled to announce its results for the fourth quarter of 2024 before the market ...

A federal judge denied a bid by CVS Health, Cigna and UnitedHealth Group to block the Federal Trade Commission's pricing case ...

CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total ...

CVS Health topped fourth-quarter earnings estimates, but still saw profit slide 38% from a year ago. "We have continued to ...

CVS Health steered through rising costs in its insurance division to handily beat profit expectations on Wall Street. The ...

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...